Exploring patient experience and satisfaction with depot buprenorphine formulations
A mixed‐methods study
Bibliographic Data
| ID | 21596876 |
|---|---|
| Authors | Eve Allen (0000-0002-8307-3429, UniSA Clinical and Health Sciences University of South Australia Adelaide Australia, corresponding author), Sona Samadian (Drug and Alcohol Services South Australia SA Health Adelaide Australia), Gary Altobelli (Drug and Alcohol Services South Australia SA Health Adelaide Australia), Jacinta L Johnson (0000-0003-4786-022X, University of South Australia), Jacinta Johnson (UniSA Clinical and Health Sciences University of South Australia Adelaide Australia), Chris Holmwood (Drug and Alcohol Services South Australia SA Health Adelaide Australia) |
| Year | 2023 |
| Volume | 42 |
| Issue | 4 |
| Pages | 791-802 |
| Publication date | 2023-05-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Drug and Alcohol Review (JOURNAL) |
| Journal identifiers | ISSN: 0959-5236 • E-ISSN: 1465-3362 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/dar.13616 |
| PMID | 36788357 |
| OpenAlex | W4320857787 |
| Language | EN |
| Citations received | 7 |
| References cited | 30 |
Attendance · Buprenorphine · Depot · Dosing · Family medicine · Methadone · Opioid · Opioid use disorder · Patient satisfaction · Psychiatry · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Internal Medicine · Pharmacology
Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (Laib) for the Treatment of Opioid Use Disorder
Long-Acting Injectable Buprenorphine for Opioid Use Disorder
Patient satisfaction with long-acting injectable buprenorphine
Reported patient experiences of extended-release buprenorphine for opioid dependence
Making long‐acting treatment work
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
Regimes of Drug Desires
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Using the framework method for the analysis of qualitative data in multi-disciplinary health research
Development and validation of the scale to assess satisfaction with medications for addiction treatment – Buprenorphine-naloxone for heroin addiction (Sasmat-Bunher)
Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms
Informed consent to opioid agonist maintenance treatment
| Citations per year | 3.5 |
|---|---|
| Citation span | 2024 - 2026 (3) |
| Highly cited | No |